BPG is committed to discovery and dissemination of knowledge
Case Control Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Dec 27, 2025; 17(12): 112038
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.112038
Table 1 Comparison of general baseline information among the 3 groups
Groups
n
Age (years)
Example (M:F)
Colorectal cancer primary diagnostic group3861.97 ± 8.8724:14
Colorectal polyp group4360.56 ± 9.8223:20
Healthy control group2956.93 ± 7.0916:13
P value0.070.66
Table 2 Comparison of antinuclear antibody positivity rate among the 3 groups
Groups
n
Positive
Negative
Positivity rate (%)
Colorectal cancer primary diagnostic group38191950.00
Colorectal polyp group43202346.51
Healthy control group292276.90
P value0.0004
Table 3 Intergroup comparison of antinuclear antibody positivity rates between the 3 groups
Comparison between groups
Colorectal cancer primary diagnostic group - colorectal polyp group
Colorectal cancer primary diagnostic group - healthy control group
Colorectal polyp group - healthy control group
P value10.020.03
Table 4 Positive analysis of titers in the 3 groups
Groups
Low titer (1:100)
Medium titer (1:320)
High titer (1:1000)
Colorectal cancer primary diagnostic group1162
Colorectal polyp group1650
Healthy control group200
P value10.004/